13F reference period
Q2 2026
Security Snapshot
Roivant Sciences Ltd. - Common Stock (ROIV) Institutional Ownership
CUSIP: G76279101
13F Institutional Holders and Ownership History from Q4 2021 to Q3 2026
Institutions Reporting
498
Shares (Excl. Options)
556.81M
Full value: 556,812,082 · shares · 30 Jun 2026Price
$35.39
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ROIV on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 556,812,082
- Total 13F value
- $19,707,870,923
- Portfolio coverage rank
- 0.03%
- Share change
- +27,270,990
- Value change
- +$1,003,554,489
- Number of holders
- 498
- Shares outstanding
- 722,990,037
- SEC-reported price per share
- $34.59
- Insider filing price
- $34.59
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- ROIV - Roivant Sciences Ltd. - Common Stock is tracked under CUSIP G76279101.
- 498 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 444 to 498 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$14.67B
Full value: $14,670,096,259 · USD · 31 Mar 2026.$19.71B
Full value: $19,707,870,923 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 498 institutions filings for Q2 2026.
Security key
G76279101
13F reference period
Q2 2026
13F holders
498
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
ROIV full holder history
Roivant Sciences Ltd. SEC filings
Roivant Sciences Ltd. company facts
Roivant Sciences Ltd. insider transactions
Roivant Sciences Ltd. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G76279101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
ROIV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 10% | +8% | $1,691,539,587 | +$180,585,293 | 73,641,253 | +12% | FMR LLC | 27 Feb 2026 |
| BlackRock, Inc. | 8.2% | $2,168,059,142 | 59,285,183 | BlackRock, Inc. | 30 Sep 2026 | |||
| MORGAN STANLEY | 5.7% | -17% | $1,440,138,931 | -$310,740,090 | 40,693,386 | -18% | Morgan Stanley | 30 Jun 2026 |
| QVT Financial LP | 4.3% | -55% | $319,084,556 | -$395,435,884 | 29,381,635 | -55% | QVT Financial LP | 30 Jun 2025 |
| Ramaswamy Vivek | 3.6% | -46% | $723,405,700 | -$648,581,977 | 25,534,970 | -47% | Ramaswamy Vivek | 31 Mar 2026 |
| VIKING GLOBAL INVESTORS LP | 3.4% | -32% | $356,989,793 | -$161,027,803 | 23,594,831 | -31% | VIKING GLOBAL INVESTORS LP | 30 Sep 2025 |
| SB INVESTMENT ADVISERS (UK) LTD | 2.3% | -58% | $357,488,273 | -$520,575,193 | 16,413,603 | -59% | SB Investment Advisers (UK) Limited | 31 Dec 2025 |
As of 30 Jun 2026,
498
institutional investors reported holding
shares of
Roivant Sciences Ltd. - Common Stock (ROIV).
This represents
77%
of the company’s total
outstanding shares.
556.81M
Full value: 556,812,082 · shares · 30 Jun 2026722.99M
Full value: 722,990,037 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
58%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 11% | 81,020,390 | +3.9% | 0.12% | $2,867,311,587 |
| BlackRock, Inc. | 6.7% | 48,236,091 | +9% | 0.03% | $1,707,075,250 |
| MORGAN STANLEY | 5.9% | 42,592,905 | -18% | 0.08% | $1,507,362,964 |
| QVT Financial LP | 3.3% | 23,723,074 | -5.7% | 54% | $839,559,589 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1% | 22,123,198 | +7% | 0.02% | $782,939,977 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3% | 21,641,339 | +9.1% | 0.03% | $765,886,987 |
| GOLDMAN SACHS GROUP INC | 2.6% | 18,556,458 | +67% | 0.07% | $656,713,035 |
| STATE STREET CORP | 2.5% | 17,795,975 | +9.9% | 0.02% | $629,799,555 |
| UBS Group AG | 2.4% | 17,466,641 | -23% | 0.1% | $618,144,425 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2% | 14,309,000 | +48% | 3% | $506,395,510 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 11,674,380 | +15% | 0.02% | $425,535,991 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.4% | 10,349,328 | -19% | 0.51% | $366,262,718 |
| Two Seas Capital LP | 1.2% | 8,475,356 | -9.1% | 11% | $299,942,849 |
| Assenagon Asset Management S.A. | 1.2% | 8,362,952 | +18% | 0.38% | $295,964,871 |
| PERCEPTIVE ADVISORS LLC | 1.1% | 8,085,461 | -2.4% | 4.4% | $286,144,465 |
| Patient Square Capital LP | 1.1% | 8,020,928 | -1.8% | 44% | $283,860,642 |
| Invesco Ltd. | 1% | 7,531,192 | +17% | 0.02% | $266,528,885 |
| Darwin Global Management, Ltd. | 0.93% | 6,747,300 | -0.74% | 6.2% | $234,333,729 |
| AQR CAPITAL MANAGEMENT LLC | 0.92% | 6,633,560 | +12% | 0.08% | $234,031,996 |
| VIKING GLOBAL INVESTORS LP | 0.87% | 6,271,467 | -5.7% | 0.63% | $221,947,217 |
| Rubric Capital Management LP | 0.83% | 6,000,000 | +20% | 1.9% | $212,340,000 |
| CITADEL ADVISORS LLC | 0.77% | 5,576,261 | +122% | 0.11% | $197,343,877 |
| DIMENSIONAL FUND ADVISORS LP | 0.72% | 5,230,417 | -30% | 0.03% | $185,062,802 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.67% | 4,816,741 | -31% | 0.02% | $170,465,000 |
| NORGES BANK | 0.66% | 4,747,472 | 0.02% | $168,013,034 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Headline period
Q2 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 23,235,435 | $849,517,592 | -$20,203,206 | $36.57 | 132 |
| 2026 Q2 | 556,812,082 | $19,707,870,923 | +$1,003,554,489 | $35.39 | 498 |
| 2026 Q1 | 530,265,977 | $14,670,096,259 | +$592,590,464 | $27.70 | 444 |
| 2025 Q4 | 508,798,279 | $11,037,472,271 | +$194,822,522 | $21.70 | 396 |
| 2025 Q3 | 501,599,656 | $7,589,044,056 | -$160,221,313 | $15.13 | 336 |
| 2025 Q2 | 514,772,354 | $5,801,411,223 | -$418,510,172 | $11.27 | 337 |
| 2025 Q1 | 553,328,719 | $5,583,781,669 | -$111,475,682 | $10.09 | 310 |
| 2024 Q4 | 562,446,665 | $6,653,171,538 | -$86,396,710 | $11.83 | 312 |
| 2024 Q3 | 569,136,749 | $6,567,461,922 | +$223,573,966 | $11.54 | 291 |
| 2024 Q2 | 546,001,457 | $5,771,073,920 | +$151,629,366 | $10.57 | 293 |
| 2024 Q1 | 531,561,894 | $5,603,149,203 | -$165,817,358 | $10.54 | 258 |
| 2023 Q4 | 541,631,584 | $6,081,436,620 | -$171,734,221 | $11.23 | 223 |
| 2023 Q3 | 545,872,779 | $6,375,349,918 | +$537,705,852 | $11.68 | 205 |
| 2023 Q2 | 497,346,775 | $5,012,967,398 | +$397,737,203 | $10.08 | 178 |
| 2023 Q1 | 459,356,125 | $3,389,932,964 | +$349,480,110 | $7.38 | 144 |
| 2022 Q4 | 411,727,361 | $3,289,525,255 | +$291,883,961 | $7.99 | 107 |
| 2022 Q3 | 370,512,297 | $1,192,938,093 | +$30,768,202 | $3.22 | 75 |
| 2022 Q2 | 360,483,554 | $1,467,028,314 | +$45,607,814 | $4.07 | 71 |
| 2022 Q1 | 349,161,599 | $1,724,680,470 | +$48,168,384 | $4.94 | 50 |
| 2021 Q4 | 339,213,133 | $3,416,732,000 | +$3,374,253,000 | $10.08 | 40 |